Explore
Validate
Learn
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 16043-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#16043-1-AP, RRID:AB_2063712
- Product name
- BCCIP antibody
- Antibody type
- Polyclonal
- Description
- KD/KO validated BCCIP antibody (Cat. #16043-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: IF, IP, WB,ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references BCCIPβ facilitates p53 ubiquitination via binding with E6 protein in high-risk HPV positive head and neck squamous cell carcinoma.
YY1/BCCIP Coordinately Regulates P53-Responsive Element (p53RE)-Mediated Transactivation of p21(Waf1/Cip1).
BCCIP binds to and activates its promoter in a YY1-dependent fashion in HCT116 cells.
Human INO80/YY1 chromatin remodeling complex transcriptionally regulates the BRCA2- and CDKN1A-interacting protein (BCCIP) in cells.
Differential BCCIP gene expression in primary human ovarian cancer, renal cell carcinoma and colorectal cancer tissues.
Wang F, Wang J, Wang J, Zhang L, Fu H, Li J, Tian T, Zuo J, Lv W, Ma X
Biochemical and biophysical research communications 2020 Aug 27;529(3):685-691
Biochemical and biophysical research communications 2020 Aug 27;529(3):685-691
YY1/BCCIP Coordinately Regulates P53-Responsive Element (p53RE)-Mediated Transactivation of p21(Waf1/Cip1).
Sui Y, Wu T, Li F, Wang F, Cai Y, Jin J
International journal of molecular sciences 2019 Apr 28;20(9)
International journal of molecular sciences 2019 Apr 28;20(9)
BCCIP binds to and activates its promoter in a YY1-dependent fashion in HCT116 cells.
Sui Y, Li F, Wu T, Ding J, Lu Z, Wang L, Yang Y, Wang F, Zhao L, Zhu H, Wei T, Jin J, Cai Y
The FEBS journal 2018 Aug;285(16):3026-3040
The FEBS journal 2018 Aug;285(16):3026-3040
Human INO80/YY1 chromatin remodeling complex transcriptionally regulates the BRCA2- and CDKN1A-interacting protein (BCCIP) in cells.
Su J, Sui Y, Ding J, Li F, Shen S, Yang Y, Lu Z, Wang F, Cao L, Liu X, Jin J, Cai Y
Protein & cell 2016 Oct;7(10):749-760
Protein & cell 2016 Oct;7(10):749-760
Differential BCCIP gene expression in primary human ovarian cancer, renal cell carcinoma and colorectal cancer tissues.
Liu X, Cao L, Ni J, Liu N, Zhao X, Wang Y, Zhu L, Wang L, Wang J, Yue Y, Cai Y, Jin J
International journal of oncology 2013 Dec;43(6):1925-34
International journal of oncology 2013 Dec;43(6):1925-34
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The BCCIP antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human BCCIP. This antibody recognizes human, mouse, rat antigen. The BCCIP antibody has been validated for the following applications: ELISA, WB analysis.
